450 filings
Page 14 of 23
EFFECT
bin8qp33gv 87cd
12 Jun 17
Notice of effectiveness
12:00am
8-K
lhw6uc69se
9 Jun 17
Departure of Directors or Certain Officers
12:00am
CORRESP
wqjetga761p837u21
9 Jun 17
Correspondence with SEC
12:00am
8-K
k6yt7fmd7w isqmk0u70
8 Jun 17
Other Events
12:00am
UPLOAD
d2af7
8 Jun 17
Letter from SEC
12:00am
8-K
vm0x5jmh onb
18 May 17
Recro Pharma Presents Phase III Bunionectomy Clinical Data for IV
12:00am
8-K
g23dikcp
18 May 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
hi4iu7
11 May 17
Recro Pharma Reports First Quarter 2017 Financial Results
12:00am
8-K
ti08mh a8t5fkeq
9 May 17
Recro Pharma Announces SuccessfulTop-Line Results from Phase III Safety Study of IV Meloxicam
12:00am
CT ORDER
kzqcpiraj 8tmm
8 May 17
Confidential treatment order
12:00am
8-K
piiw67zumziudcel
5 Apr 17
Other Events
12:00am
DEFA14A
mdeqcoz
28 Mar 17
Additional proxy soliciting materials
12:00am
S-8
18fzl bmsn
9 Mar 17
Registration of securities for employees
12:00am
S-8
lmhqr
9 Mar 17
Registration of securities for employees
12:00am
8-K
isfw 5n5b8b
7 Mar 17
Recro Pharma Reports Year End 2016 Financial Results
12:00am
8-K
ka7xp
6 Mar 17
Recro Pharma Appoints Bryan Reasons to Its Board of Directors
12:00am